Scott K Van Why
Overview
Explore the profile of Scott K Van Why including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh V, Van Why S
Med Clin North Am
. 2023 Nov;
108(1):157-172.
PMID: 37951648
Monogenic hypertension encompasses a group of conditions wherein single gene mutations result in increased renal sodium reabsorption manifesting as low renin hypertension. As these diseases are rare, their contribution to...
2.
Van Why S, Pan C
Crit Care Clin
. 2022 Apr;
38(2):375-391.
PMID: 35369952
Hypertensive crisis, especially in children, is a rare condition and is defined as a sudden and abrupt elevation in blood pressure that poses a threat of rapid onset of end-organ...
3.
Varnell C, Fukuda T, Kirby C, Martin L, Warshaw B, Patel H, et al.
Pediatr Transplant
. 2017 Sep;
21(7).
PMID: 28869324
MMF is commonly prescribed following kidney transplantation, yet its use is complicated by leukopenia. Understanding the genetics mediating this risk will help clinicians administer MMF safely. We evaluated 284 patients...
4.
Bick D, Fraser P, Gutzeit M, Harris J, Hambuch T, Helbling D, et al.
J Pediatr Genet
. 2017 May;
6(2):61-76.
PMID: 28496993
A pilot program was initiated using whole genome sequencing (WGS) to diagnose suspected genetic disorders in the Genetics Clinic at Children's Hospital of Wisconsin. Twenty-two patients underwent WGS between 2010...
5.
Coogle L, Holland K, Pan C, Van Why S
Pediatr Transplant
. 2016 Dec;
21(2).
PMID: 28019062
TS of immunosuppression is a rare, disfiguring dermatologic condition caused by TS-associated polyomavirus in immunosuppressed patients. It is difficult to treat, with no clearly described approach to resolve the condition...
6.
Sreedharan R, Van Why S
Pediatr Nephrol
. 2016 Feb;
31(10):1561-70.
PMID: 26913726
Heat shock proteins (Hsps) are essential to cell survival through their function as protein chaperones. The role they play in kidney health and disease is varied. Hsp induction may be...
7.
Sreedharan R, Chen S, Miller M, Haribhai D, Williams C, Van Why S
Kidney Int
. 2014 May;
86(3):515-24.
PMID: 24805105
Inducible heat shock proteins (HSPs), regulated by heat shock factor-1 (HSF-1), protect against renal cell injury in vitro. To determine whether HSPs ameliorate ischemic renal injury in vivo, HSF-1 functional...
8.
Basile D, Dwinell M, Wang S, Shames B, Donohoe D, Chen S, et al.
Kidney Int
. 2012 Dec;
83(2):242-50.
PMID: 23235564
Brown Norway rats (BN, BN/NHsdMcwi) are profoundly resistant to developing acute kidney injury (AKI) following ischemia reperfusion. To help define the genetic basis for this resistance, we used consomic rats,...
9.
Hogg R, Friedman A, Greene T, Radeva M, Budisavljevic M, Gassman J, et al.
Clin J Am Soc Nephrol
. 2012 Nov;
8(2):211-8.
PMID: 23143503
Background And Objectives: In the FSGS Clinical Trial, 22 cyclosporine-treated and 20 mycophenolate/dexamethasone-treated patients experienced a complete or partial remission after 26 weeks, completed 52 weeks of treatment, and were...
10.
Regner K, Zuk A, Van Why S, Shames B, Ryan R, Falck J, et al.
Kidney Int
. 2008 Dec;
75(5):511-7.
PMID: 19052533
While it is known that the arachidonic acid metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to ischemic injury in the heart and brain, its role in kidney injury is unclear. Here we...